Development of a computational approach to predict blood-brain barrier permeability

Drug Metabolism and Disposition

Volumn 32, Issue 1, 2004, Pages 132-139

  Liu, Xingrong ^a   Tu, Meihua ^a   Kelly, Rebecca S ^a   Chen, Cuiping ^a   Smith, Bill J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CHLORAMBUCIL; COLCHICINE; DAUNORUBICIN; DIGOXIN; DOPAMINE; ESTRADIOL; FLUOXETINE; GLYCINE; HYPOXANTHINE; LEVODOPA; MANNITOL; METHOTREXATE; MORPHINE; PHENAZONE; PHENYLALANINE; PHENYTOIN; PROPRANOLOL; QUINIDINE; RIMONABANT; SALICYLIC ACID; SUCROSE; TAUROCHOLIC ACID; TESTOSTERONE; THEOBROMINE; THEOPHYLLINE; UNINDEXED DRUG; VALPROIC ACID; XANTHINE;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; DRUG DIFFUSION; DRUG PENETRATION; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; NONHUMAN; PASSIVE TRANSPORT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SURFACE PROPERTY;

ALGORITHMS; ANIMALS; ARTIFICIAL INTELLIGENCE; BLOOD-BRAIN BARRIER; CEREBRAL CORTEX; CHEMISTRY, PHYSICAL; COMPUTATIONAL BIOLOGY; INDICATORS AND REAGENTS; MALE; PERFUSION; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 1642579680     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.32.1.132     Document Type: Article

References (37)

1. Abraham MH and Chadha HS (1996) Applications of a solvation equation to drug transport properties, in Lipophilicity in Drug Action and Toxicity (Pliska V, Testa B, and van de Waterbeemd H eds) pp 311-337, Wiley-VCH, Weinheim. Germany.
2. Abraham MH, Chadha HS, and Mitchell RC (1994) Hydrogen bonding. 33. The factors that influence the distribution of solutes between blood and brain. J Pharm Sci 83:1257-1268.
3. Abraham MH, Chadha HS, and Mitchell RC (1995) The factors that influence the skin permeation of solutes. J Pharm Pharmacol 47:8-16.
4. Adachi Y, Suzuki H, and Sugiyama Y (2001) Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res (NY) 18:1660-1668.
5. Alexander GM, Schwartzman RJ, Grothusen JR, and Gordon SW (1994) Effect of plasma levels of large neutral amino acids and degree of parkinsonism on the blood-to-brain transport of levodopa in naive and MPTP parkinsonian monkeys. Neurology 44:1491-1499.
6. Butt AM and Jones HC (1992) Effect of histamine and antagonists on electrical resistance across the blood-brain barrier in rat brain-surface microvessels. Brain Res 569:100-105.
7. Chen C and Pollack GM (1998) Altered disposition and antinociception of [D-penicillamine(2,5)] enkephalin in mdr1a-gene-deficient mice. J Phannacol Exp Ther 287:545-552.
8. Chikhale EG, Ng KY, Burton PS, and Borchardt RT (1994) Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm Res (NY) 11:412-419.
9. Clark DE (1999) Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci 88:815-821.
10. Dagenais C, Rousselle C, Pollack GM, and Scherrmann JM (2000) Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice, J Cereb Blood Flow Metab 20:381-386.
11. Davson H and Segal MB (1995) Physiology of the CSF and Blood-Brain Barriers. CRC Press, Inc, Boca Raton, FL.
12. Ertl P, Rohde B, and Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714-3717.
13. Fromm MF, Kim RB, Stein CM, Wilkinson GR, and Roden DM (1999) Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine. Circulation 99:552-557.
14. Gratton JA, Abraham MH, Bradbury MW, and Chadha HS (1997) Molecular factors influencing drug transfer across the blood-brain barrier. J Pharm Pharmacol 49:1211-1216.
15. Kalvass JC and Maurer TS (2002) Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery, Biopharm Drug Dispos 23:327-338.
16. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, and Endou H (1999) Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274:13675-13680.
17. Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M, and Sugiyama Y (1997) P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier. J Pharmacol Exp Ther 283:574-580.
18. Levin VA (1980) Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 23:682-684.
19. Lobell M, Molnar L, and Keseru GM (2002) Recent advances in the prediction of blood-brain partitioning from molecular structure. J Pharm Sci 92:360-370.
20. Lombardo F, Blake JF, and Curatolo WJ (1996) Computation of brain-blood partitioning of organic solutes via free energy calculations. J Med Chem 39:4750-4755.
21. Momma S, Aoyagi M, Rapoport SI, and Smith QR (1987) Phenylalanine transport across the blood-brain barrier as studied with the in situ brain perfusion technique. J Neurochem 48:1291-1300.
22. Murakami H, Takanaga H, Matsuo H, Ohtani H, and Sawada Y (2000) Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique. Am J Physiol 279:H1022-H1028.
23. Nagata Y, Kusuhara H, Endou H, and Sugiyama Y (2002) Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol Pharmacol 61:982-988.
24. Norinder U and Haeberlein M (2002) Computational approaches to the prediction of the blood-brain distribution. Adv Drug Deliv Rev 54:291-313.
25. Platts JA, Abraham MH, Zhao YH, Hersey A, Ijaz L, and Butina D (2001) Correlation and prediction of a large blood-brain distribution data set-an LFER study. Eur J Med Chem 36:719-730.
26. Platts JA, Butina D, Abraham MH, and Hersey A (1999) Estimation of molecular linear free energy relation descriptors using a group contribution approach. J Chem Inf Comput Sci 39:835-845.
27. Rizzi M, Caccia S, Guiso G, Richichi C, Gorter JA, Aronica E, Aliprandi M, Bagnati R, Fanelli R, D'Incalci M, et al. (2002) Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance. J Neurosci 22:5833-5839.
28. Sanchez del Pino MM, Peterson DR, and Hawkins RA (1995) Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier. J Biol Chem 270:14913-14918.
29. Schinkel AH, Wagenaar E, van Deemter L, Mol CAAM, and Borst P (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. J Clin Investig 96:1698-1705.
30. Smith BJ, Doran AC, McLean S, Tingley FD 3rd, O'Neill BT, and Kajiji SM (2001) P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists. J Pharmacol Exp Ther 298:1252-1259.
31. Smith QR (1989) Quantitation of blood-brain barrier permeability, in Implications of the Blood-Brain Barrier and its Manipulation (Neuwelt E ed) vol 1, pp 85-118, Plenum Press, New York.
32. Smith QR (1996) Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system, in Models for Assessing Drug Absorption and Metabolism (Borchardt RT, Smith PL, and Wilson G, eds) pp 285-307, Plenum Press, New York.
33. Smith QR and Takasato Y (1986) Kinetics of amino acid transport at the blood-brain barrier studied using an in situ brain perfusion technique. Ann NY Acad Sci 481:186-201.
34. Takasato Y, Rapoport SI, and Quentin RS (1984) An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 247:H484-H493.
35. Uhr M, Steckler T, Yassouridis A, and Holsboer F (2000) Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption. Neuropsychopharmacology 22:380-387.
36. Wade LA and Katzman R (1975) Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier. J Neurochem 25:837-842.
37. Xie R, Hammarlund-Udenaes M, de Boer AG, and de Lange ECM (1999) The role of P-glycoprotein in blood-brain barrier transport of morphine: trancortical microdyalysis studies in mdr1a(-/-) and mdr1a (+/+) mice. Br J Pharmacol 128:563-568.